About Us

“In every disease there is a latency period and in this stage if we are able to detect the disease we can go for treatment before it becomes lethal.” – Karley et al

The Biostability Experts

We believe the best path to research, diagnose, and treat disease is putting information-rich tissue into an immediate state of suspended animation. Before tissue degrades, blood clots, or molecules begin to dissociate.

The challenge? It has to be done without interfering in the assays or diagnostic tests. It must work in areas without refrigeration. And, it can’t be expensive.

Our key products achieve this: successfully suspending biomarkers in blood, saliva, tissue, and other bodily fluids.

But there is more to do. And while not everyone on the Biomatrica team is a researcher, everyone wants cures to come faster and does their part, be it in operations, shipping, or finance.

If you want to find out more about biomarker preservation or our other preservation solutions, please reach out – we want to hear from you!

Contact Us

Our Leadership Team

Click on any team member’s name or picture to learn more.

General Manager
Vice President, Global Sales & Marketing
Associate Director of Product Development
Associate Director, Product Support and Validations
Associate Director of Quality
Associate Director of Research & Technology

Key Facts about Biomatrica

  • Over 30 published patents with more filed/pending

  • Established in 2005 and now a wholly owned subsidiary of Exact Sciences Corporation

  • Portfolio: Stabilization of blood, saliva, tissue and other bodily fluids

  • Certifications: ISO 13485:2016, CE-IVD mark on select products

  • Headquartered in San Diego, California

Our Guidance Team

Scientific Advisory

Scientific Advisor
Scientific Advisor
Scientific Advisor

Hard Lessons Learned:

Impacts of Pre-Analytical Variance on Liquid Biopsy Clinical Trials

 This white-paper explores how upstream assay factors impacted six clinical trials. Encompassing both regional and global teams, learn the commonalities in six trials that initially fell short and the likely responsible mechanisms.

Download White-Paper

Get the Most from Your Assay

We Can Help You:

Improve Sensitivity
Reduce Pre-analytical Variations
Ease Shipping & Storage Logistics
Increase User Compliance
Improve Assay Throughput

Contact Us & Learn More